5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.77%
Negative revenue growth while VALMT.HE stands at 15.75%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
4.85%
Gross profit growth under 50% of VALMT.HE's 12.65%. Michael Burry would be concerned about a severe competitive disadvantage.
-106.45%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-106.45%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-48.94%
Negative net income growth while VALMT.HE stands at 17.44%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.48%
Negative EPS growth while VALMT.HE is at 17.02%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-48.48%
Negative diluted EPS growth while VALMT.HE is at 17.02%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.27%
OCF growth at 50-75% of VALMT.HE's 114.04%. Martin Whitman would question if the firm lags in monetizing sales effectively.
78.55%
FCF growth 50-75% of VALMT.HE's 126.67%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-10.52%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 81.41%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-6.75%
Negative 5Y CAGR while VALMT.HE stands at 23.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.35%
Negative 3Y CAGR while VALMT.HE stands at 4.27%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
282.17%
10Y OCF/share CAGR at 75-90% of VALMT.HE's 359.15%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
313.21%
Positive OCF/share growth while VALMT.HE is negative. John Neff might see a comparative advantage in operational cash viability.
52.30%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
-92.17%
Negative 10Y net income/share CAGR while VALMT.HE is at 231.50%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-95.17%
Negative 5Y net income/share CAGR while VALMT.HE is 10.89%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.17%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
126.55%
10Y equity/share CAGR at 75-90% of VALMT.HE's 156.25%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
44.92%
Below 50% of VALMT.HE's 120.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
36.06%
Below 50% of VALMT.HE's 83.13%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.97%
Firm’s AR is declining while VALMT.HE shows 10.82%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.14%
Inventory is declining while VALMT.HE stands at 2.64%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.88%
Asset growth well under 50% of VALMT.HE's 7.73%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.87%
50-75% of VALMT.HE's 3.25%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-1.33%
We’re deleveraging while VALMT.HE stands at 40.66%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
20.82%
SG&A growth well above VALMT.HE's 3.83%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.